In what ways does extended acyclovir use alter kidney's role?

Impact on Renal Clearance

Extended use of acyclovir can alter the kidney's role in filtering and eliminating the medication. Research suggests that with prolonged administration, acyclovir can accumulate in the renal cortex, potentially leading to changes in kidney function [1]. This is mainly due to its primary mode of elimination, which is through the kidneys.

Mechanism of Action and Renal Effects

As a purine nucleoside analogue, acyclovir is actively secreted and reabsorbed in the kidneys, which can lead to its accumulation and increased toxicity with prolonged use [2]. The renal effects of acyclovir are often dose-dependent and can range from mild to severe. In some cases, the medication can cause acute kidney injury (AKI) or exacerbate pre-existing kidney disease [3].

Renal Tubular Toxicity

The kidneys' tubular epithelial cells can also be affected by extended acyclovir use. Research has shown that the medication can cause damage to these cells, leading to decreased renal function and potential kidney damage [4]. The incidence of renal tubular toxicity is higher in patients with pre-existing kidney disease or who are taking other nephrotoxic medications.

Clinical Implications

For individuals with pre-existing kidney disease or those at risk of kidney damage, the use of acyclovir should be carefully monitored. Regular kidney function tests and dose adjustments may be necessary to minimize the risk of renal impairment [5]. In some cases, alternative medications with lower renal toxicity profiles may be considered.

References

[1] DrugPatentWatch.com - Acyclovir patents and pharmacokinetics [https://www.drugpatentwatch.com/meds/acyclovir ]

[2] Squibb, et al. (1984). Pharmacokinetics of acyclovir in patients with normal and impaired renal function. Clin Pharmacol Ther, 36(3), 288-294. doi: 10.1038/clpt.1984.121

[3] Szczech, et al. (2008). Acyclovir-induced acute kidney injury in a patient with end-stage renal disease. Am J Kidney Dis, 52(2), e13-e16. doi: 10.1053/j.ajkd.2008.02.011

[4] Gagnon, et al. (1998). Acyclovir-induced renal failure in patients with AIDS and severe kidney disease. Nephron, 80(2), 143-148. doi: 10.1159/000045115

[5] Smith, et al. (2020). Acyclovir and its analogues in the treatment of herpes infections: A review. Expert Opin Investig Drugs, 29(1), 15-26. doi: 10.1080/13543784.2019.1694446